Associate Professor of Medicine, Case West Res University
Hematology
Dr. Afshin Dowlati, MD
|
|
Give Review
Doctor Afshin Dowlati, MD is an expert in the field of Hematology. He has 3 awards "America's Top Doctors", "America's Top Doctors for Cancer" and "Top MD". Afshin Dowlati is a published doctor. He published 22 publications, including: 'Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?' Afshin Dowlati is registered with Medicare and accepts Medicare payments.
Publications
- Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?
- Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.
- PIAS3 expression in squamous cell lung Cancer is low and predicts overall survival.
- CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma.
- Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival.
- Quinacrine Overcomes Resistance to Erlotinib by Inhibiting FACT, NF-κB, and Cell-Cycle Progression in Non-Small Cell Lung Cancer.
- RET Mutation and Expression in Small-Cell Lung Cancer.
- Defining subgroups of small-cell lung Cancer.
- Dual VEGF/VEGFR inhibition in advanced solid Malignancies: Clinical effects and pharmacodynamic biomarkers.
- Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial Ovarian, peritoneal, o...
- Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung Cancer.
- PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung Cancer cells independent of p53 status.
- Synthesis and AntiCancer Mechanism Investigation of Dual Hsp27 and Tubulin Inhibitors.
- Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal Cancers.
- A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal Cancer.
- Phase I trials of targeted antiCancer drugs: a need to refocus.
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid.
- Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based Analysis of variables affecting 10- to 18-yea...
- Identification of a class of novel tubulin inhibitors.
- Phase-II Trial of Rebeccamycin Analog, a Dual Topoisomerase-I and -II Inhibitor, in Relapsed "Sensitive" Small Cell Lung Cancer.
- Pharmacogenomic approach to identify drug sensitivity in small-cell lung Cancer.
Schools
Universite De Liege Faculte De Medecine
University Liege
Case West Res UUniv Hosps Of Cleveland
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top MD
Education
-
Case Western Reserve University - University Hospitals -
Universite de L'Etat a Liege Faculty of Medicine
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1528084852 | |
| NPPES Provider LastName | DOWLATI | |
| NPPES Provider FirstName | AFSHIN | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 390.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 4.1 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528084852 |
| Last Name Of The Provider | DOWLATI |
| First Name Of The Provider | AFSHIN |
| View All |
Similar Doctors
|
Dr. Ronald M. Sobecks, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Stanton L. Gerson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bernard J. Silver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manmeet S. Ahluwalia, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Aleksandr Lazaryan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yael Hegerfeldt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cheng E. Chee, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nathan Levitan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mir Y. Ali, MD |
|
Dr. Cindylou F. Connell, MD
This Doctor is OpenDoctor Recommended.
|